% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Buchholz:279169,
author = {Buchholz, Maresa and Pfaff, Michelle and Iskandar, Audrey
and Reetz, Kathrin and Schulz, Jörg B and Grobe-Einsler,
Marcus and Klockgether, Thomas and Michalowsky, Bernhard},
collaboration = {Group, EFACTS Study},
othercontributors = {Boesch, Sylvia and Nachbauer, Wolfgang and Eigentler,
Andreas and Indelicato, Elisabetta and Amprosi, Matthias and
Rai, Myriam and Pandolfo, Massimo and Mariotti, Caterina and
Nanetti, Lorenzo and Gellera, Cinzia and Mongelli, Alessia
and Castaldo, Anna and Fichera, Mario and Bertini, Enrico
and Vasco, Gessica and Durr, Alexandra and Ewenczyk, Claire
and Biet, Marie and Monin, Marie Lorraine and Holtbernd,
Florian and Brcina, Nikolina and Hohenfeld, Christian and
Didszun, Claire and Dogan, Imis and Giordano, Ilaria and
Klopstock, Thomas and Stendel, Claudia and Radelfahr,
Florentine and Bischoff, Almut and Schöls, Ludger and
Hayer, Stefanie and Koutsis, Georgios and Breza, Marianthi
and Palau, Francesc and O'Callaghan, Mar and de Rivera
Garrido, Francisco Javier Rodríguez and Rummey, Christian
and Giunti, Paola and Parkinson, Michael H and Thomas-Black,
Gilbert and Manso, Katarina and Solanky, Nita and Labrum,
Robyn},
title = {{H}ealth-{R}elated {Q}uality of {L}ife in {P}atients with
{F}riedreich {A}taxia {U}sing {M}obility {A}ssistive
{T}echnologies: {L}imited {F}it of the {EQ}-5{D}-3{L}
{M}obility {D}imension.},
journal = {Neurology and Therapy},
volume = {14},
number = {1},
issn = {2193-6536},
address = {Heidelberg [u.a.]},
publisher = {Springer},
reportid = {DZNE-2025-00697},
pages = {379 - 398},
year = {2025},
abstract = {Friedreich Ataxia (FA) is a multisystem neurodegenerative
disease. Affected individuals rely on mobility assistive
technologies (MAT) (e.g. wheelchairs) and require long-term
treatments and care. To analyse the patients' health-related
quality of life (HRQoL), the EuroQol 5 Dimension 3 Level
survey (EQ-5D-3L)-a widely used and recommended generic
measure-is used in clinical and in health economic studies.
Concerns about using the instrument in mobility-impaired
individuals who might have difficulties finding appropriate
response options for mobility-related items led us to
investigate how the 3L dimensions perform in patients with
FA using or not using MAT.Using longitudinal data from 607
patients with FA of the EFACTS study (from baseline to the
3-year follow-up), we analysed the acceptability,
distribution properties, validity, and responsiveness of the
EQ-5D-3L, focusing on the mobility item. Analyses were
stratified for patients without and with different
MAT-usage.We identified that n = 177 patients used no MAT, n
= 299 a wheelchair and n = 131 walking aids. The mobility
item non-response was highest in wheelchair users $(6.8\%)$
and lowest in patients without MAT. Walking aid users showed
the least variability, all selecting the mid-response option
'some problems' for mobility. The mobility item correlated
moderately with disease severity (rsp = 0.35) and the
activities of daily living scale (rsp = 0.36) in wheelchair
users. No correlation exists for walking aid users. The
strongest health changes occurred for wheelchair users, the
weakest for walking aid users. The mobility dimensions
showed the highest amount of no changes.The EQ-5D-3L's
mobility item has limitations in MAT users, particularly in
walking aid users, due to a tendency towards mid-responses.
These limitations may affect the efficacy and
(cost)effectiveness conclusions drawn from interventions and
clinical trials with mobility-impaired individuals. Further
research is needed to explore the understanding and
interpretation of responses of the EQ-5D in patients with FA
with mobility support.ClinicalTrials.gov identifier
NCT02069509.},
keywords = {EQ-5D-3L (Other) / Friedreich Ataxia (Other) /
Health-related quality of life (Other) / Mobility assistive
technology (Other)},
cin = {AG Michalowsky / AG Thyrian / AG Hoffmann / Clinical
Research (Bonn) / Patient Studies (Bonn)},
ddc = {610},
cid = {I:(DE-2719)5000067 / I:(DE-2719)1510800 /
I:(DE-2719)1510600 / I:(DE-2719)1011001 /
I:(DE-2719)1011101},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39738982},
pmc = {pmc:PMC11762039},
doi = {10.1007/s40120-024-00694-7},
url = {https://pub.dzne.de/record/279169},
}